GlobeVerge
Home / world
WORLD
GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
GlobeSignal
World Watch
Developments like this can have effects beyond the immediate story.
Expand ▾
More in General
- Affordability is a 'defining challenge' for Americans, with food costs leading the way, report finds
- Frustrated commuters endure three months of disrupted rail services
- Elrigh Louw opens up on how Springboks dream carried him during 10-month rehab journey
- 'Marked increase' in peptide users utilising needle exchange facilities
GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.